Infrared Sciences Corporation has developed a screening process, the Sentinel BreastScan, which employs digital infrared imaging to detect breast cancer with a high degree of accuracy and at a very early stage. The product is an adjunctive1 test that physicians use to screen for and isolate pre-cancerous and cancerous tumors. The company provides the systems to gynecologists, radiologists, medical oncologist, hospitals, third-party imaging centers, and women's health centers for use as an adjunctive screening tool to mammography. When used in a program that combines infrared with other modalities, the Sentinel BreastScan is expected to significantly increase the early detection of breast cancer. The Sentinel BreastScan was granted FDA 510(k) approval in 2004 and it's European Union CE Mark in 2006.
Link to this comment:
All Comments (0)